| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±3.0% | +2.2% | over-priced |
| February 6, 2026 | ±4.5% | -2.0% | over-priced |
| November 7, 2025 | ±2.8% | -1.4% | over-priced |
| May 12, 2025 | ±2.8% | +0.4% | over-priced |
| February 7, 2025 | ±2.3% | -0.0% | over-priced |
| November 8, 2024 | ±2.7% | -0.1% | over-priced |
| May 9, 2024 | ±2.1% | +2.1% | over-priced |
| February 8, 2024 | ±2.7% | +2.9% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.71 | $636M | $123M |
| Q2 FY2026 | $1.72 | $619M | $125M |
| Q1 FY2026 | $1.97 | $645M | $144M |
| Q4 FY2025 | $1.75 | $615M | $128M |
Henry (Jack) & Associates (JKHY) reports in 76 days, with the next report estimated for August 28, 2026. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced JKHY's earnings risk. Fundamentals into the print: EPS up 12.5% year-over-year, revenue up 8.7%. QuantLogix's live 5-factor engine currently reads JKHY as a neutral at 45/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →